Skip to main content
    S

    Sight Sciences Inc (SGHT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $10.59
    -0.24 (-2.22%)

    Market Cap: $601.92M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Sight Sciences Inc (SGHT) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Sight Sciences (SGHT) to earn -$0.46 per share in the fiscal year ending Dec 31, 2026, on revenue of $92.59M. Of 8 analysts, 6 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 2.13, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 75% of the ratings.

    RatingAnalystsShare
    Strong Buy112.5%
    Buy562.5%
    Hold225.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    8

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 12.2%.

    Fiscal year ending Dec 31, 2026
    -$0.46
    EPS consensus, revenue $92.59M
    Fiscal year ending Dec 31, 2027
    -$0.36
    EPS consensus, revenue $103.88M
    Next report
    Mar 2, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.46-$0.61 to -$0.286$92.59M$92.00M to $92.95M8
    Dec 31, 2027-$0.36-$0.52 to -$0.206$103.88M$101.30M to $105.41M8

    Quarterly Estimates

    The EPS consensus rises from -$0.14 for the quarter ending Dec 31, 2026 to -$0.12 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.14-$0.17 to -$0.089$25.15M$23.27M to $27.20M10
    Mar 31, 2027-$0.12-$0.16 to -$0.074$22.88M$22.50M to $23.13M5

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 3 upward and 2 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202721
    Quarter ending Mar 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.49.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.46-$0.49-$0.49-$0.49-$0.49N/A
    Fiscal year ending Dec 31, 2027-$0.36-$0.40-$0.43-$0.43-$0.43N/A
    Quarter ending Mar 31, 2027-$0.12-$0.07-$0.06-$0.06-$0.06N/A

    Frequently Asked Questions About SGHT

    What is the SGHT stock forecast?

    Consensus analyst estimates put Sight Sciences's EPS at -$0.46 for the fiscal year ending Dec 31, 2026, on revenue of $92.59M. The consensus rating from 8 analysts is Buy.

    How do analysts rate SGHT stock?

    Of 8 analysts covering Sight Sciences, 1 rates it Strong Buy, 5 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from SGHT next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.46, with estimates from -$0.61 to -$0.28 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.36, with estimates from -$0.52 to -$0.20 from 6 analysts.

    What revenue do analysts expect from Sight Sciences next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $92.59M, with estimates from $92.00M to $92.95M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $103.88M, with estimates from $101.30M to $105.41M.

    How many analysts cover SGHT?

    8 analysts rate Sight Sciences stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.